Terrence L Graham

US Patent:

20040033902, Feb 19, 2004

Filed:

Aug 12, 2002

Appl. No.:

10/203513

Inventors:

William Haddad - Danville OH, US
Neil Badenhop - Pemberville OH, US
Alan Stammen - St. Henry OH, US
Theodore Bean - Franklin PA, US
Terrence Graham - Hilliard OH, US
Serena Landini - Columbus OH, US

International Classification:

A01N037/44
A01N037/18
A01N031/14

US Classification:

504/322000, 504/334000, 504/352000

Abstract:

The invention relates to a method for inducing systemic resistance in plants, thereby protecting plants against a broad range of plant pathogens and disease. The method of the invention comprises the application of a biologically active formulation, comprising a diphenyl ether, to a plant. In accordance with the invention, it has been observed that use of this formulation results in induced systemic resistance in a target plant. Also in accordance with the method of the invention, the formulation has been shown to trigger long-lasting, non-specific systemic resistance in the plant to a variety of pathogens and disease. Furthermore, the method of the invention results in an increase in the levels of plant isoflavones.

US Patent:

20020004458, Jan 10, 2002

Filed:

Feb 12, 2001

Appl. No.:

09/781695

Inventors:

Terrence Graham - Hilliard OH, US
Serena Landini - Columbus OH, US

International Classification:

A01N037/00
A01N035/00
A01N031/00

US Classification:

504/320000, 504/348000, 504/353000

Abstract:

Methods for increasing the levels of isoflavones in plants are provided. The method comprise applying a biologically effective amount of composition comprising a select nuclear receptor ligand to the plant. Compositions for inducing the production of isoflavones in plants are also provided. Such compositions comprise one or preferably, a combination of the select nuclear receptor ligands. The compositions also comprise a compound that enhances the capacity of the plant to release daidzein and/or utilize it for the production of glyceollin. The action of such a compound is complementary to that of the nuclear receptor ligand.